November 5, 2021
Japan on November 5 granted special emergency approval for Chugai Pharmaceutical’s antibody cocktail Ronapreve (casirivimab + imdevimab) for an addition indication of the prevention of symptomatic SARS-CoV-2 infection, or COVID-19. Along with this, the drug’s subcutaneous use was also given...read more